---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-039387"
form_type: "8-K"
ticker: "KPTI"
cik: "0001503802"
company_name: "Karyopharm Therapeutics Inc."
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T23:01:29.093047+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Karyopharm regains Nasdaq minimum bid price compliance

## Summary
- Nasdaq confirmed Karyopharm regained compliance with Bid Price Rule on Feb 16, 2024.
- Company met $1.00 minimum closing bid for 10 consecutive business days through Feb 15, 2024.
- Non-compliance was first disclosed on Dec 12, 2023; this resolves the listing deficiency.
- No effect on business operations or financial condition.

## SEC filing metadata
- accession: 0001193125-24-039387
- form_type: 8-K
- ticker: KPTI
- cik: 0001503802
- company_name: Karyopharm Therapeutics Inc.
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/0001193125-24-039387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/d774101d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-039387
- JSON: https://secwatch.observer/filing/0001193125-24-039387.json
- Plain text: https://secwatch.observer/filing/0001193125-24-039387.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.